This inventor holds 1 USPTO granted patent. Top assignees: Helmholtz-Zentrum Für, Infektionsforschung Gmbh. Active years: 2021.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2021
Title: Tim Mollner: Innovator in Cystobactamide Derivatives
Introduction
Tim Mollner is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating bacterial infections. His work exemplifies the intersection of innovation and practical application in healthcare.
Latest Patents
Tim Mollner holds a patent for "Cystobactamide derivatives." This invention relates to novel derivatives of cystobactamides and their use for the treatment or prophylaxis of bacterial infections. The patent highlights the potential of these compounds in addressing critical health challenges posed by bacterial pathogens.
Career Highlights
Throughout his career, Tim Mollner has worked with esteemed organizations, including Helmholtz-Zentrum für Infektionsforschung GmbH. His role in these institutions has allowed him to contribute to groundbreaking research and development in the field of infectious diseases.
Collaborations
Tim Mollner has collaborated with notable colleagues such as Hans-Peter Prochnow and Antje Ritter. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in their shared field of research.
Conclusion
Tim Mollner's contributions to the field of medicinal chemistry, particularly through his patent on cystobactamide derivatives, underscore his role as an innovator in combating bacterial infections. His work continues to inspire advancements in healthcare solutions.